000 01242 a2200361 4500
005 20250517211440.0
008 ####s 0 0 eng d
022 _a2053-8790
024 7 _a10.1136/lupus-2018-000261
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRiggs, Jeffrey M
245 0 0 _aCharacterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus.
_h[electronic resource]
260 _bLupus science & medicine
_c2018
300 _ae000261 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aHanna, Richard N
700 1 _aRajan, Bhargavi
700 1 _aZerrouki, Kamelia
700 1 _aKarnell, Jodi L
700 1 _aSagar, Divya
700 1 _aVainshtein, Inna
700 1 _aFarmer, Erika
700 1 _aRosenthal, Kimberly
700 1 _aMorehouse, Chris
700 1 _ade Los Reyes, Melissa
700 1 _aSchifferli, Kevin
700 1 _aLiang, Meina
700 1 _aSanjuan, Miguel A
700 1 _aSims, Gary P
700 1 _aKolbeck, Roland
773 0 _tLupus science & medicine
_gvol. 5
_gno. 1
_gp. e000261
856 4 0 _uhttps://doi.org/10.1136/lupus-2018-000261
_zAvailable from publisher's website
999 _c28276314
_d28276314